In vitro exposure of sheep ovarian tissue to the xenoestrogens zearalenone and enterolactone: Effects on preantral follicles.
Follicular development
Gene expression
In vitro culture
Mycoestrogen
Phytoestrogen
Journal
Theriogenology
ISSN: 1879-3231
Titre abrégé: Theriogenology
Pays: United States
ID NLM: 0421510
Informations de publication
Date de publication:
15 Oct 2021
15 Oct 2021
Historique:
received:
19
04
2021
revised:
10
08
2021
accepted:
19
08
2021
pubmed:
25
8
2021
medline:
16
9
2021
entrez:
24
8
2021
Statut:
ppublish
Résumé
The aim of this study was to evaluate the effect of 1 μmol/L zearalenone (ZEN) and 1 μmol/L enterolactone (ENL), alone or in combination, on the survival and morphology of in vitro cultured ovarian preantral follicles. Ovaries from 10 sheep were collected at a local abattoir and fragmented, and the ovarian pieces were submitted to in vitro culture for 3 days in the presence or absence of the test compounds. The morphology of primordial and primary follicles was impaired by ZEN, whereas that of cultured secondary follicles was improved by ENL. However, the combination of ENL with ZEN impaired the quality of primary and secondary follicles. Both ZEN and ENL induced apoptosis, but only ZEN was responsible for oocyte autophagy. None of these xenoestrogens affected endoplasmic reticulum stress as observed by the unaltered expression of ERP29. Differently from ZEN, ENL increased the expression of the efflux transporter ABCG2. In conclusion, although ENL can counteract the negative effects of ZEN on primordial and primary follicles, this positive effect is not similar to that observed in ovarian tissue cultures in the presence of ENL alone.
Identifiants
pubmed: 34428678
pii: S0093-691X(21)00298-3
doi: 10.1016/j.theriogenology.2021.08.025
pii:
doi:
Substances chimiques
Lignans
0
Zearalenone
5W827M159J
4-Butyrolactone
OL659KIY4X
2,3-bis(3'-hydroxybenzyl)butyrolactone
X01E7E1D6H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
124-130Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest to disclose.